Steroid pics
This was followed by a complete purification in 1935 by Laquer. steroid pics Cancun-steroids. A year later, Ruzicka achieved the synthesis of the identical compound, testosterone, from cholesterol, as did Butenandt and Hanisch. 3In 1936, Kochakian succeeded in demonstrating that use of testosterone or testosterone acetate reduced urinary nitrogen excretion of the castrated dog and increased body weight. 4 Kenyon later showed that testosterone was a potent anabolic substance in man as well. steroid pics Bodybuilding diet. The Development of Analogues and DerivativesKochakian states in (9) that his work with the mouse, showing that androstane-3a,17�-diol was preferentially renotrophic while androstenedione preferentially increased the size of the seminal vesicles and prostate, together with findings that 19-nortestosterone (nandrolone) had a preferential effect on the levator ani muscle of the rat, served as an impetus for the development of drugs that might be exclusively or largely protein anabolic for use in debilitated patients. Between 1948 and 1955, chemists at Searle had synthesized more than a thousand different testosterone derivatives and analogues. Using an assay developed by Hershberger which measured the effect of a test compound both on the prostate and levator ani of the castrated rat, these compounds were screened both orally and parenterally under the direction of Saunders and Drill. steroid pics High carbohydrate diet. 1 It was implicitly assumed that activity on the levator ani would be indicative of a drug's therapeutic effects, while activity on the castrated rat prostate would be a sufficient and accurate predictor of all of a drug's numerous and varied potential "androgenic" side effects on humans of both sexes. It was a particular research goal of this project to find drugs which would be effective orally, since testosterone itself was not very potent via that route of administration. One compound, a 17-ethylated, 19-normethyl analogue of testosterone, appeared to be superior to others. By Hershberger's assay method, it was found to be only 1/16 as "androgenic" (prostatotrophic) than it was "anabolic" (potent in inducing growth in the rat levator ani, a sex-specific muscle). Other workers obtained myotrophic: androgenic dissociation ratios of 2:1, 3. 5:1, 20:1, 1. 3:1, 4:1, 3. 1:1, and 7. 1 relative to testosterone. 5 These values are clearly inconsistent but such was typical with this assay method. Searle's animal tests indicated no significant toxicity to the drug, which they named Nilevar (norethandrolone). In clinical tests, the drug was found beneficial for nutritionally depleted cardiac patients, gastrectomy patients, chronically underweight men, women, and children, and some doctors even used norethandrolone "almost routinely to hasten the convalescence of hospitalized children. "4 The drug was FDA approved in 1956 and still sees some use today, although it has been shown to be slightly hepatotoxic. 6Numerous other drugs were developed which, like norethandrolone, were simple modifications of the testosterone structure. Only two, which shall be described later, appear clearly superior to norethandrolone for use as a protein anabolic where minimization of virilizing side effects is desired. Many are similar, and many are worse as regards toxicity and/or clinical androgenicity and other side effects. Certain more substantially modified structures, to be described, have properties extending beyond protein anabolism which make them therapeutically useful for treatment of several diseases. Presently Known Clinical Activities of TestosteroneIn the human, testosterone is known to improve protein anabolism in depleted individuals, and at supraphysiological levels, it can increase protein anabolism in healthy individuals. It can also maintain or improve bone density. These properties are classified as anabolic. Androgenic properties include, for the male, development and maintenance of male sexual characteristics, induction or acceleration of development of male pattern baldness, and enlargement of the prostate. In the female, they can include induction of hirsutism, hoarsening and lowering of the voice, change in skin texture, menstrual irregularities, growth of cartilage of the nose, and enlargement of the clitoris. Other effects which may be experienced by either sex include acne, increased aggression, increased libido, or other mood changes. Many of the tissues experiencing these effects have high levels of 5a- reductase, an enzyme which converts testosterone to dihydrotestosterone (DHT). Other effects, not readily categorizable as either anabolic or androgenic, include edema, suppression of LH/FSH, gynecomastia in the male, hypertension, and maturation of immature epiphyseal plates. These effects may be caused partly or entirely by the conversion of testosterone to estradiol in the body, accomplished principally by CYP 19 aromatase. Other effects include hypertension, reduction of HDL blood lipid, decreased blood clotting time, enlarged heart, CNS stimulation which may lead to insomnia or headaches, and reversible reduction or loss of fertility in the male. Testosterone is also known to modulate the immune system7 and to have other metabolic effects not discussed here. These activities appear to be primarily the result of the ability of testosterone or certain of its metabolites, particularly DHT, to bind to the androgen receptor (AR) of cells. The AR then binds to DNA and increases the transcription of certain genes; this concept was proposed by Jensen and Jacobsen in 1963.
Steroid pics
Fat burning soup diet || Steroids-and-baseball || Steroids women || Steroids women